Comparison of Absorbability Between Calcium Tablet and Calcium Ion Water
Information source: Hiroshima University
ClinicalTrials.gov processed this data on August 20, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Healthy
Intervention: Calcium tablet (Dietary Supplement); Calcium ion water (250mg) (Dietary Supplement); Calcium ion water (125mg) (Dietary Supplement)
Phase: N/A
Status: Completed
Sponsored by: Hiroshima University Official(s) and/or principal investigator(s): Fumiko Higashikawa, PhD, Principal Investigator, Affiliation: Hiroshima University
Summary
The purpose of this study is to evaluate the absorbability of calcium tablet and calcium ion
water.
Clinical Details
Official title: A Randomized, Double-blind, Crossover Study to Compare the Absorbability Between Calcium Tablet and Calcium Ion Water
Study design: Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention
Primary outcome: Serum calcium profile (including AUC, Cmax, and Tmax)
Eligibility
Minimum age: 55 Years.
Maximum age: 70 Years.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- Postmenopausal females
Exclusion Criteria:
- Taking medicines or functional food that affect serum calcium levels
- Diseases that affect bone
- Renal or hepatic dysfunction
- Heart disease
- Participation in any clinical trial within 90 days of the commencement of the trial
Locations and Contacts
Hiroshima University, Hiroshima, 734-8551, Japan
Additional Information
Starting date: November 2012
Last updated: March 26, 2013
|